First Time Loading...

Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR

Watchlist Manager
Arrowhead Pharmaceuticals Inc Logo
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Watchlist
Price: 23.42 USD -2.05%
Updated: Jun 10, 2024

Arrowhead Pharmaceuticals Inc
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arrowhead Pharmaceuticals Inc
Accumulated Depreciation Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Accumulated Depreciation
-$50m
CAGR 3-Years
-38%
CAGR 5-Years
-36%
CAGR 10-Years
-30%
Abbvie Inc
NYSE:ABBV
Accumulated Depreciation
-$6.7B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Arrowhead Pharmaceuticals Inc's Accumulated Depreciation?
Accumulated Depreciation
-50m USD

Based on the financial report for Mar 31, 2024, Arrowhead Pharmaceuticals Inc's Accumulated Depreciation amounts to -50m USD.

What is Arrowhead Pharmaceuticals Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 10Y
-30%

Over the last year, the Accumulated Depreciation growth was -38%. The average annual Accumulated Depreciation growth rates for Arrowhead Pharmaceuticals Inc have been -38% over the past three years , -36% over the past five years , and -30% over the past ten years .